Trial Profile
A Single-centre, Open-label Study of Multiple Doses of Tipranavir 500 mg and Ritonavir 200 mg (Twice Daily) on the Pharmacokinetic Characteristics of Methadone Administered as a Single Dose in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2014
Price :
$35
*
At a glance
- Drugs Tipranavir (Primary) ; Methadone; Ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 26 Sep 2014 New trial record